Ask your provider to show the pharmacy license, batch testing records, and whether its semaglutide base, not salt
P.PangeniR.JhaS
Ongoing Support and Monitoring: We offer ongoing support and regular check-ups to monitor your progress, address any concerns, and make necessary adjustments to your treatment plan
Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT
News provided by University of Colorado Anschutz Jul 29, 2026, 00:00 ET A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
Histological features include epidermal atrophy and increased number of melanocytes